Akeso’s US$5 Billion Licensing Agreement With Summit Therapeutics Title

Martina Bellini
Tagged:

Sidley advised Akeso Inc. on the deal.Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific antibody,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now